Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Crosstalk of Cancer Genomic Test and Cancer Immune Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy - 1 Mar 2022

Nishihara Hiroshi

Abstract excerpt

Based on the"neoantigen theory", the measurement of microsatellite instability(MSI)and tumor mutation burden(TMB) is one of the essential test items during cancer precision medicine, especially for the administration of immune checkpoint inhibitor. The conventional MSI test is consist of direct PCR method to amplify the microsatellite region using DNA derived from tumor specimen as a companion diagnostic(CDx)for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neoplasms
Share to Biomarkers, Tumor
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microsatellite Instability

Share to Mutation

Source

Identifiers

PMID: 35299175

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Crosstalk of Cancer Genomic Test and Cancer Immune Therapy].PMID 35299175Read ↗

Personalized immunotherapy in cancer precision medicineSemantic proximity Read ↗

Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer.Semantic proximity Read ↗

DNA Repair and Signaling in Immune-Related Cancer TherapySemantic proximity Read ↗

Viewpoint: The Current Advances and Future Optimization of Blood-based Tumor Mutation Burden as a Biomarker for Cancer ImmunotherapySemantic proximity Read ↗

[Management of Cancer Genomic Board and Preparation of Genomic Report].Semantic proximity Read ↗

Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancerSemantic proximity Read ↗

Epigenetic Perspective of Immunotherapy for CancersSemantic proximity Read ↗

[Genome analysis and cancer therapy].Semantic proximity Read ↗

Beneath the Surface: Neoantigens beyond Chromosomal DNA Mutations.Semantic proximity Read ↗

Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy.Semantic proximity Read ↗

Targeting DNA Damage Response and Repair Genes to Enhance Anticancer Immunotherapy: Rationale and Clinical ImplicationSemantic proximity Read ↗

Co-mutations in tumor immune microenvironment and immunotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.